Yan Wenlong, Wang Yangyang, Zheng Xin, Guo Pengfei, Yang Sumin
Department of Cardiovascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Department of Nuclear Medicine, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Front Cardiovasc Med. 2023 Mar 3;10:1076049. doi: 10.3389/fcvm.2023.1076049. eCollection 2023.
Valve replacement combined with coronary artery bypass graft (CABG) operation (VR + CABG) is usually associated with higher mortality and complication rates. Currently, angiography remains the most commonly used approach to guide CABG. The aim of this study is to investigate whether a quantitative flow ratio (QFR)-guided strategy can improve the clinical outcomes of VR + CABG.
Patients ( = 536) treated by VR + CABG between January 2018 and December 2021 were retrospectively assessed. In 116 patients, all lesions were revascularized entirely based on QFR (the QFR-guided group), whereas in 420 patients, all lesions were revascularized entirely based on angiography (the angiography-guided group). To minimize selection bias between the 2 groups, propensity score matching was performed at a ratio of 1:2. The primary endpoint of the study was the rate of major adverse cardiac and cerebrovascular events (MACCE) at 1-year, which was defined as a composite of cardiac mortality, myocardial infarction (MI), any repeat revascularization, and stroke.
No statistically significant differences were observed in the baseline clinical characteristics between the QFR-guided and angiography-guided groups after propensity score matching. The mean age of all patients was 66.2 years [standard deviation (SD) = 8.3], 370 (69%) were men, the mean body-mass index of the population was 24.8 kg/m (SD = 4.5), 129 (24%) had diabetes, and 229 (43%) had angina symptoms. When compared with the angiography-guided group, the QFR-guided group had a significantly shorter operative time (323 ± 60 min vs. 343 ± 71 min, = 0.010), extra corporal circulation time (137 ± 38 min vs. 155 ± 62 min, = 0.004), clamp time (73 ± 19 min vs. 81 ± 18 min, < 0.001), and less intraoperative bleeding volume (640 ± 148 ml vs. 682 ± 166 ml, = 0.022). Compared with the angiography-guided group, the 1-year MACCE was significantly lower in the QFR-guided group (6.9% vs. 14.7%, = 0.036, hazard ratio = 0.455, 95% confidence interval: 0.211-0.982).
Our results raise the hypothesis that among patients who undergo VR + CABG, QFR-guided strategy is associated with optimized surgical procedure and a superior clinical outcome, as evidenced by a lower rate of MACCE at 1-year compared with conventional angiography-guided strategy.
瓣膜置换术联合冠状动脉旁路移植术(VR + CABG)通常与较高的死亡率和并发症发生率相关。目前,血管造影仍是指导冠状动脉旁路移植术最常用的方法。本研究的目的是探讨定量血流比(QFR)指导策略是否能改善VR + CABG的临床结局。
回顾性评估2018年1月至2021年12月期间接受VR + CABG治疗的患者(n = 536)。在116例患者中,所有病变均完全基于QFR进行血运重建(QFR指导组),而在420例患者中,所有病变均完全基于血管造影进行血运重建(血管造影指导组)。为尽量减少两组之间的选择偏倚,以1:2的比例进行倾向评分匹配。该研究的主要终点是1年时的主要不良心脑血管事件(MACCE)发生率,其定义为心脏死亡、心肌梗死(MI)、任何再次血运重建和中风的综合结果。
倾向评分匹配后,QFR指导组和血管造影指导组的基线临床特征未观察到统计学上的显著差异。所有患者的平均年龄为66.2岁[标准差(SD)= 8.3],370例(69%)为男性,总体平均体重指数为24.8 kg/m²(SD = 4.5),129例(24%)患有糖尿病,229例(43%)有胸痛症状。与血管造影指导组相比,QFR指导组的手术时间显著缩短(323 ± 60分钟 vs. 343 ± 71分钟,P = 0.010),体外循环时间(137 ± 38分钟 vs. 155 ± 62分钟,P = 0.004),夹闭时间(73 ± 19分钟 vs. 81 ± 18分钟,P < 0.001),术中出血量也更少(640 ± 148毫升 vs. 682 ± 166毫升,P = 0.022)。与血管造影指导组相比,QFR指导组1年时的MACCE显著更低(6.9% vs. 14.7%,P = 0.036,风险比 = 0.455,95%置信区间:0.211 - 0.982)。
我们的结果提出了一个假设,即在接受VR + CABG的患者中,QFR指导策略与优化的手术过程和更好的临床结局相关,与传统血管造影指导策略相比,1年时MACCE发生率更低证明了这一点。